Literature DB >> 2227485

New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma.

E P Messmer1, W Sauerwein, T Heinrich, W Höpping, D Klueter-Reckmann, N Bornfeld, H Sack, M Förster, W Havers.   

Abstract

The study is based on a retrospective analysis of data from 200 patients with hereditary retinoblastoma. Apart from four unilateral cases with a positive family history all patients had bilateral disease; 229 appeared suitable for conservative treatment while 167 eyes had to be enucleated. Primary local treatment was performed in 102 eyes, while 127 eyes received primary external beam radiation using a linear accelerator. Follow-up was adjusted by life tables, with 75% of the patients being observed longer than 2 years. Using life-table statistics new and recurrent tumors were found in 41% of all patients and in 95% of these cases they were noted within 26 months after initiation of therapy. Among eyes treated with primary external beam radiation new and recurrent tumors were observed significantly less frequently when 50 Gy (22% compared with 49% after 40 Gy) and a highly accurate beam alignment technique (22% compared with 48% after alignment to the outer bony canthus) were applied. The incidence of recurrent tumors following primary local treatment did not differ significantly with regard to the application of either photo- or cryocoagulation (28% vs 33%), while no recurrence was observed among tumors that were suitable for primary treatment using ruthenium or cobalt plaques.

Entities:  

Mesh:

Year:  1990        PMID: 2227485     DOI: 10.1007/bf00927255

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

1.  beta-Irradiation of retinoblastoma with 106Ru/106Rh applicators.

Authors:  P Lommatzsch
Journal:  Mod Probl Ophthalmol       Date:  1977

2.  Retinoblastoma treated with a 60Co applicator.

Authors:  E Kock; B Rosengren; B Tengroth; E af Trampe
Journal:  Radiother Oncol       Date:  1986-09       Impact factor: 6.280

3.  Mitosis in the nontumorous parts of the retina with retinoblastoma.

Authors:  F Nakao
Journal:  Ophthalmologica       Date:  1978       Impact factor: 3.250

4.  Non-ocular cancer in patients with hereditary retinoblastoma and their relatives.

Authors:  D J DerKinderen; J W Koten; N J Nagelkerke; K E Tan; F A Beemer; W Den Otter
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

5.  [Treatment of retinoblastoma (author's transl)].

Authors:  A Balmer; C Gailloud
Journal:  Klin Monbl Augenheilkd       Date:  1979-06       Impact factor: 0.700

6.  Treatment of bilateral groups I through III retinoblastoma with bilateral radiation.

Authors:  D H Abramson; R M Ellsworth; P Tretter; J Javitt; F D Kitchin
Journal:  Arch Ophthalmol       Date:  1981-10

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  Incidence of second neoplasms in patients with bilateral retinoblastoma.

Authors:  J D Roarty; I W McLean; L E Zimmerman
Journal:  Ophthalmology       Date:  1988-11       Impact factor: 12.079

9.  Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced?

Authors:  D H Abramson; R M Ellsworth; F D Kitchin; G Tung
Journal:  Ophthalmology       Date:  1984-11       Impact factor: 12.079

10.  Second primary neoplasms in patients with retinoblastoma.

Authors:  G J Draper; B M Sanders; J E Kingston
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

View more
  4 in total

1.  Long-term results after low dose ocular irradiation for choroidal haemangiomas.

Authors:  H Schilling; W Sauerwein; A Lommatzsch; W Friedrichs; S Brylak; N Bornfeld; A Wessing
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

2.  External beam radiotherapy for retinoblastoma: II. Lens sparing technique.

Authors:  N M Toma; J L Hungerford; P N Plowman; J E Kingston; D Doughty
Journal:  Br J Ophthalmol       Date:  1995-02       Impact factor: 4.638

3.  Long-term treatment effects in patients with bilateral retinoblastoma: ocular and mid-facial findings.

Authors:  E P Messmer; H Fritze; C Mohr; T Heinrich; W Sauerwein; W Havers; B Horsthemke; W Höpping
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

Review 4.  Radiotherapy for ocular tumours.

Authors:  C Stannard; W Sauerwein; G Maree; K Lecuona
Journal:  Eye (Lond)       Date:  2012-11-23       Impact factor: 3.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.